This inventor holds 183 USPTO granted patents and 57 published patent applications and 6 EPO patents, primarily in Plasma Processing (CPC class H01J37-32834). Top assignees: Applied Materials, Inc., Nantomics, LLC, Asml Holding N.v.. Active years: 2001-2026.
Inventors with similar research interests:
Location History:
- Santa Clara, CA (US) (2004)
- San Jose, CA (US) (2001 - 2024)
- Culver City, CA (US) (2022 - 2024)
Company Filing History:
143 out of 14,418 
15 out of 66 
8 out of 629 
Years Active: 2001-2026
Areas of Expertise:
Title: Andrew Nguyen: Revolutionizing Cancer Treatment Through Innovative Patents
Introduction:
Andrew Nguyen, a brilliant innovator and patent holder based in San Jose, California, is making significant strides in the field of cancer treatment. With an impressive portfolio of 162 patents, Nguyen's latest inventions focus on the iterative discovery of neoepitopes and adaptive immunotherapy. These advancements hold great potential in transforming the way we approach cancer treatments. Let's explore his latest patents, career highlights, and notable collaborations.
Latest Patents:
Among Nguyen's recent breakthroughs, two patents stand out for their groundbreaking potential. The first patent, "Iterative Discovery of Neoepitopes and Adaptive Immunotherapy and Methods Therefor," centers around recursive analysis of patient-specific neoepitopes obtained from multiple biopsy sites. This approach allows for informed decision-making in developing targeted cancer treatments, combining immunotherapy and chemotherapy.
The second patent, "Systems, Compositions, and Methods for Discovery of MSI and Neoepitopes that Predict Sensitivity to Checkpoint Inhibitors," focuses on predicting tumor response to checkpoint inhibitors by evaluating the quantity and characteristics of immunologically visible neoepitopes. Patterns within the neoepitope's nucleic acid encoding can further indicate treatment response.
Career Highlights:
Throughout his career, Nguyen has made notable contributions to various forward-thinking companies. One of his ventures was with Applied Materials, Inc, a leading provider of materials engineering solutions for the semiconductor industry. Nguyen played a key role in developing innovative technologies to enhance device performance and efficiency.
Nguyen's collaboration with Nantomics, LLC, a precision medicine company, took his creativity to new heights. As a crucial member of the team, he dedicated his expertise to improving diagnostic and therapeutic solutions for cancer patients. Nguyen's patents reflect his profound commitment to revolutionizing cancer treatments and helping individuals battle this devastating disease.
Collaborations:
Within his professional journey, Nguyen has had the privilege of working alongside esteemed colleagues such as Kartik Ramaswamy and Kenneth S. Collins. These collaborations have fostered an environment of innovation and have played a pivotal role in the development of Nguyen's groundbreaking patents. Their combined expertise and dedication have further accelerated advancements in cancer research and treatment strategies.
Conclusion:
Andrew Nguyen's exceptional contributions in the field of cancer treatment have been recognized through his impressive patent portfolio. His latest inventions offer promising avenues for improving patient-specific therapeutic approaches and predicting treatment response. With his career highlights and notable collaborations, Nguyen continues to drive innovation at the intersection of immunotherapy, diagnostic analysis, and precision medicine. Undoubtedly, his work serves as an inspiration, fostering hope for a brighter future in the fight against cancer.